179 related articles for article (PubMed ID: 9728602)
1. Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists.
Hartwell EA
Am J Clin Pathol; 1998 Sep; 110(3):281-92. PubMed ID: 9728602
[TBL] [Abstract][Full Text] [Related]
2. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient.
Judd WJ; Luban NL; Ness PM; Silberstein LE; Stroup M; Widmann FK
Transfusion; 1990 Feb; 30(2):175-83. PubMed ID: 2154871
[No Abstract] [Full Text] [Related]
3. Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: survey of laboratory practice.
Ramsey G;
Arch Pathol Lab Med; 2009 Mar; 133(3):465-9. PubMed ID: 19260751
[TBL] [Abstract][Full Text] [Related]
4. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
5. Utilization of Rh prophylaxis.
Berger GS; Keith L
Clin Obstet Gynecol; 1982 Jun; 25(2):267-75. PubMed ID: 6179676
[TBL] [Abstract][Full Text] [Related]
6. The continuing struggle to eliminate hemolytic disease of the newborn from RH (D).
Barlow JF
S D J Med; 1999 Jan; 52(1):7-8. PubMed ID: 9926725
[No Abstract] [Full Text] [Related]
7. Reversal of Rh alloimmunization. Fact or fancy?
Bowman JM; Pollock JM
Vox Sang; 1984; 47(3):209-15. PubMed ID: 6087562
[TBL] [Abstract][Full Text] [Related]
8. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
9. Preventing rhesus isoimmunization. Antepartum Rh immune globulin prophylaxis versus a sensitive test for risk identification.
Hensleigh PA
Am J Obstet Gynecol; 1983 Aug; 146(7):749-55. PubMed ID: 6307052
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
[No Abstract] [Full Text] [Related]
11. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
Branch DR; Scofield TL; Moulds JJ; Swanson JL
Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
[TBL] [Abstract][Full Text] [Related]
12. Pathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement.
Welsh KJ; Bai Y;
Am J Clin Pathol; 2016 Jun; 145(6):744-51. PubMed ID: 27267375
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantitation of fetomaternal hemorrhage.
Turner WA; Fadel HE; Krauss JS
South Med J; 1986 May; 79(5):571-5. PubMed ID: 3010476
[TBL] [Abstract][Full Text] [Related]
14. Prospective quantification of fetomaternal hemorrhage with dilation and evacuation procedures.
Hsia JK; Schimmoeller NR; Cansino CD; Hou MY; Jensen HM; Creinin MD
Contraception; 2019 May; 99(5):281-284. PubMed ID: 30500335
[TBL] [Abstract][Full Text] [Related]
15. Clinically silent massive fetomaternal hemorrhage: important lessons from an illustrative case.
Post GR; Lazarchick J; Singh ZN
Lab Hematol; 2012 Jun; 18(2):11-3. PubMed ID: 22709788
[TBL] [Abstract][Full Text] [Related]
16. The use of Rh immune globulin: a review.
Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
[No Abstract] [Full Text] [Related]
17. Management and Follow-up of Massive Fetomaternal Hemorrhage Requiring High-Dose Rh Immune Globulin: A Case Report.
Fortes PA; Gnass ED; Baez J; Bayati B; Mei Z; McGonigle AM; Ziman A; Ward DC
Am J Clin Pathol; 2023 Jul; 160(1):78-80. PubMed ID: 36897771
[TBL] [Abstract][Full Text] [Related]
18. [Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention].
Quartier P; Floch C; Meier F; Fruchart MF; Brossard Y; Lejeune C
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):517-9. PubMed ID: 8228016
[TBL] [Abstract][Full Text] [Related]
19. Detection of fetomaternal hemorrhage.
Kim YA; Makar RS
Am J Hematol; 2012 Apr; 87(4):417-23. PubMed ID: 22231030
[TBL] [Abstract][Full Text] [Related]
20. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
